This latest document is a series of FDA guidance reports that are created to keep healthcare professionals informed on the latest in the COVID-19 public health emergency (PHE).
With a rush of recent approvals to help with the coronavirus epidemic, the FDA has been fast-tracking approvals in hopes that American lives will be saved.
In-home testing has received Emergency Use Authorization, but its’ necessary to keep updated on what tests are currently approved and what tests have been withdrawn from EUA approval.
These tests could help healthcare professionals identify individuals who have developed an adaptive immune response to SARS-CoV-2 — the coronavirus that causes COVID-19.
The generic drug, once used to treat a myriad of other diseases, was unleashed against coronavirus in an attempt to wield against the virus ravaging the globe.